Detalles de la búsqueda
1.
Standardized Definitions for Cardiogenic Shock Research and Mechanical Circulatory Support Devices: Scientific Expert Panel From the Shock Academic Research Consortium (SHARC).
Circulation
; 148(14): 1113-1126, 2023 10 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-37782695
2.
Clinical Trial Design Principles and Outcomes Definitions for Device-Based Therapies for Hypertension: A Consensus Document From the Hypertension Academic Research Consortium.
Circulation
; 145(11): 847-863, 2022 03 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-35286164
3.
Latent Pulmonary Vascular Disease May Alter the Response to Therapeutic Atrial Shunt Device in Heart Failure.
Circulation
; 145(21): 1592-1604, 2022 05 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-35354306
4.
Atrial shunt device for heart failure with preserved and mildly reduced ejection fraction (REDUCE LAP-HF II): a randomised, multicentre, blinded, sham-controlled trial.
Lancet
; 399(10330): 1130-1140, 2022 03 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-35120593
5.
Retrieval of renal function after renal artery stenting improves event-free survival in a subgroup analysis of the Cardiovascular Outcomes in Renal Atherosclerotic Lesions trial.
J Vasc Surg
; 77(6): 1685-1692.e2, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36736864
6.
Definitions and Clinical Trial Design Principles for Coronary Artery Chronic Total Occlusion Therapies: CTO-ARC Consensus Recommendations.
Circulation
; 143(5): 479-500, 2021 02 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33523728
7.
Rationale and design of the safe and timely antithrombotic removal - ticagrelor (STAR-T) trial: A prospective, multi-center, double-blind, randomized controlled trial evaluating reductions in postoperative bleeding with intraoperative removal of ticagrelor by the drugsorb™-ATR device in patients undergoing cardiothoracic surgery within 48 hours from last ticagrelor dose.
Am Heart J
; 245: 19-28, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34736855
8.
Biomarkers of platelet activation and cardiovascular risk in the DAPT trial.
J Thromb Thrombolysis
; 51(3): 675-681, 2021 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-32683645
9.
2017 Cardiovascular and Stroke Endpoint Definitions for Clinical Trials.
Circulation
; 137(9): 961-972, 2018 02 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-29483172
10.
Clinical Trial Principles and Endpoint Definitions for Paravalvular Leaks in Surgical Prosthesis.
Eur Heart J
; 39(15): 1224-1245, 2018 04 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-28430909
11.
Proposed Standardized Neurological Endpoints for Cardiovascular Clinical Trials: An Academic Research Consortium Initiative.
Eur Heart J
; 39(19): 1687-1697, 2018 05 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-28171522
12.
Myocardial Infarction Risk After Discontinuation of Thienopyridine Therapy in the Randomized DAPT Study (Dual Antiplatelet Therapy).
Circulation
; 135(18): 1720-1732, 2017 May 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-28228427
13.
Ultrathin, bioresorbable polymer sirolimus-eluting stents versus thin, durable polymer everolimus-eluting stents in patients undergoing coronary revascularisation (BIOFLOW V): a randomised trial.
Lancet
; 390(10105): 1843-1852, 2017 Oct 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-28851504
14.
Factors associated with performing urgent coronary angiography in out-of-hospital cardiac arrest patients.
Catheter Cardiovasc Interv
; 91(5): 832-839, 2018 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28766924
15.
Impact of Optimal Medical Therapy in the Dual Antiplatelet Therapy Study.
Circulation
; 134(14): 989-998, 2016 Oct 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-27576774
16.
Diabetes Mellitus and Prevention of Late Myocardial Infarction After Coronary Stenting in the Randomized Dual Antiplatelet Therapy Study.
Circulation
; 133(18): 1772-82, 2016 May 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-26994121
17.
Stenting and medical therapy for atherosclerotic renal-artery stenosis.
N Engl J Med
; 370(1): 13-22, 2014 Jan 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-24245566
18.
Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents.
N Engl J Med
; 371(23): 2155-66, 2014 Dec 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-25399658
19.
Rationale of a novel study design for the BIOFLOW V study, a prospective, randomized multicenter study to assess the safety and efficacy of the Orsiro sirolimus-eluting coronary stent system using a Bayesian approach.
Am Heart J
; 193: 35-45, 2017 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-29129253
20.
Use of endpoint adjudication to improve the quality and validity of endpoint assessment for medical device development and post marketing evaluation: Rationale and best practices. A report from the cardiac safety research consortium.
Am Heart J
; 190: 76-85, 2017 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-28760216